The National Health and Medical Research Council’s (NHMRC) Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) Guideline Development Committee (ME/CFS GDC) held its sixth meeting on Friday 23 October 2026. The meeting focused on finalising the health-related outcomes that will inform the questions for evidence review (population, intervention, comparator, outcome (PICO) questions) and resulting recommendations for the ME/CFS Clinical Practice Guidelines.

Date and Time:  

  • Friday 23 October 2026 from 1:30pm to 3:30pm AEDT

Location: Virtual meeting.

Key highlights

  • Members reviewed declarations of interest and noted that no management strategies were required for this meeting.
  • Members discussed and finalised up to 7 health-related outcomes for each of the relevant PICO questions that will inform the evidence review and resulting recommendations in the ME/CFS Clinical Practice Guidelines.
  • In discussing outcomes, members considered the results of the ME/CFS Scoping Survey and the results of an out-of-session task conducted by members prior to the meeting.

Next steps

  • The ME/CFS GDC will meet to discuss the most appropriate outcome measurement tools for each prioritised health-related outcome for relevant PICO questions. The next ME/CFS GDC meeting is anticipated to be in late 2026.